These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3405313)

  • 21. Intrastriatal injection of kainic acid prevents the development of postsynaptic dopamine receptor hypersensitivity after chronic haloperidol treatment.
    Zarkovsky AM; Nurk AM; Rägo LK; Allikmets LH
    Neuropharmacology; 1982 Feb; 21(2):155-8. PubMed ID: 7199630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release.
    Osborne PG; O'Connor WT; Beck O; Ungerstedt U
    Brain Res; 1994 Jan; 634(1):20-30. PubMed ID: 7908848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of fentanyl and droperidol on the dopamine metabolism of the rat striatum.
    Freye E; Kuschinsky K
    Pharmacology; 1976; 14(1):1-7. PubMed ID: 986654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on interactions between conditioned and unconditioned behavioural responses to apomorphine in rats.
    Möller HG; Nowak K; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):673-9. PubMed ID: 3627283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic-induced catalepsy: a D2 blockade phenomenon?
    Klemm WR
    Pharmacol Biochem Behav; 1985 Dec; 23(6):911-5. PubMed ID: 2867564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conditioning and the delayed onset of a haloperidol-induced behavioral effect.
    Carey RJ
    Biol Psychiatry; 1987 Mar; 22(3):269-77. PubMed ID: 3814679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin--dopamine interactions in the nigrostriatal system.
    Waldmeier PC; Delini-Stula AA
    Eur J Pharmacol; 1979 May; 55(4):363-73. PubMed ID: 572774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of single and long-term droperidol administration on open-field and stereotyped behavior of rats.
    Frussa-Filho R; Palermo-Neto J
    Physiol Behav; 1991 Oct; 50(4):825-30. PubMed ID: 1775558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Increased tolerance of the dopamine- and serotoninergic systems during chronic administration of haloperidol and levomepromazine].
    Allikmets LKh; Zharkovskiĭ AM; Otter MIa; Khinrikus TKh
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1979; 29(5):1067-70. PubMed ID: 573939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
    Balsara JJ; Bapat TR; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced effect of haloperidol and apomorphine after hypophysectomy: pharmacokinetic considerations.
    Lloyd KG; Bianchetti G; Worms P; Morselli PL
    J Pharm Pharmacol; 1983 Mar; 35(3):166-9. PubMed ID: 6132974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy.
    Cohen SL; Knight M; Tamminga CA; Chase TN
    Eur J Pharmacol; 1982 Sep; 83(3-4):213-22. PubMed ID: 6129145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms.
    Sanberg PR; Emerich DF; el-Etri MM; Shipley MT; Zanol MD; Cahill DW; Norman AB
    Pharmacol Biochem Behav; 1993 Oct; 46(2):303-7. PubMed ID: 8265684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central antidopaminergic properties of 2-bromolisuride, an analogue of the ergot dopamine agonist lisuride.
    Wachtel H; Kehr W; Sauer G
    Life Sci; 1983 Dec; 33(26):2583-97. PubMed ID: 6607392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic drugs influence the intensity of catalepsy induced by microinjections of carbachol into the reticular formation.
    Elazar Z; Ganchrow D; Paz M; Rabinowitz R; Paz Z; Korczyn AD
    Neurosci Lett; 1990 Nov; 119(2):245-8. PubMed ID: 1980731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of conditioning with d-amphetamine on the extracellular concentration of dopamine and its metabolites in the striatum of behaving rats.
    Dietze S; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):22-7. PubMed ID: 7935850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conditioning of apomorphine effects: simultaneous analysis of the alterations in cortical electroencephalogram and behaviour.
    Kropf W; Kuschinsky K; Krieglstein J
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):559-67. PubMed ID: 1944603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pavlovian conditional tolerance to haloperidol catalepsy: evidence of dynamic adaptation in the dopaminergic system.
    Poulos CX; Hinson R
    Science; 1982 Oct; 218(4571):491-2. PubMed ID: 6889765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K; Karcz M; Wardas J; Wolfarth S
    Eur J Pharmacol; 1990 Jul; 182(2):327-34. PubMed ID: 1975782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.